Navigation Links
AssureRx Adds New CEO
Date:6/9/2009

Experienced Executive to Lead Personalized Medicine Company in Next Phase of Growth

CINCINNATI, June 9 /PRNewswire/ -- AssureRx, a personalized medicine company, announced today that James S. Burns has joined the Mason-based company as its new President and CEO.

Burns comes to AssureRx with more than 30 years of executive experience in the strategic management of science and technology for pharmaceutical, diagnostic, and biotech companies. Most recently, he was president and CEO of Maryland-based EntreMed Inc., a public clinical-stage pharmaceuticals company developing drugs for the treatment of cancer and inflammatory diseases.

Previously, he was a co-founder and president of MedPointe Pharmaceuticals Inc., a specialty pharmaceuticals company that develops, markets, and sells branded prescription pharmaceuticals. He also was founder and managing director of MedPointe Capital Partners, a private equity firm that led the buyout of a New York Stock Exchange company to form MedPointe Pharmaceuticals.

Mr. Burns was also a founder, chairman, president and CEO of Osiris Therapeutics Inc., a public biotech company developing therapeutic stem-cell products for the regeneration of damaged or diseased tissues. Previously, he was a founding general partner of Healthcare Ventures LP, a venture capital partnership specializing in forming companies built around new pharmaceutical and biotechnology products; a group president at Becton Dickinson and Co.; and a partner at Booz Allen Hamilton, a global strategy and technology consulting firm.

"We are thrilled to have a person of Jim's caliber leading the company into the next phase of its growth. His depth and breadth of experience as CEO of successful early-stage health care companies po
'/>"/>

SOURCE AssureRx
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AssureRx Adds VP of Sales and Marketing
2. AssureRx Closes Round of Funding to Commercialize Pharmacogenetic Test

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 20 Cell Therapeutics, I...hat the Ninth Circuit Court of Appeals reversed a ...d be allowed to pursue all of its claims against T...ct Court for trial. CTI filed a complaint against...ement consultant for CTI,s product TRISENOX, in 20...
(Date:11/20/2009)...TTLER TOLEDO recently announced that Dr. Dominique...Role of Process Analytical Technology (PAT) in Gre...ber 1, 2009. , (PRWEB) No... Analytical Technology (PAT) in Green Chemistry an...s Analytical Technology (PAT) case studies will be...
(Date:11/19/2009)...9 Danish Prince Joachim inaugurate...lant in Kalundborg, Denmark, on Wednesday, Novembe... largest 2nd generation ethanol demonstration bior... in the plant,s innovative process for converting ...s the first to market with commercial enzymes for ...
(Date:11/19/2009)...ov. 19 Dr. Mate Hidvegi, inventor ...o a press release issued on November 17 by Biropha...king false and self-serving statements about its U...dvegi stated from his office in Budapest, Hungary:...mar does not apply to AveULTRA, www.aveultra.com...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2
...generative medicine company developing solutions b... announced the start of the Company,s first human ... ReGenica is the first naturally stabilized and bi...factors, which are thought to act in the formation... San Diego, CA (PRWEB) November 20, 2008 -- Histog...
...els Inc. (Nasdaq: NGBF ) announced today that it...ess Energy Florida (NYSE: PGN ) to demonstrate i...r applications. , , The Agreement calls for N... test program that will be performed in early 2009...Petersburg. The test program will include the eval...
...itute (KGI) today announced that the second annua...ducation for Women in the Life Science Industry" (...l feature eight female CEOs of life science compan...GI, which specializes in the development of busine...utive Education for Women, which specializes in st...
Other Biology Technology:Histogen Announces Start of Hair Regrowth Clinical Evaluation 2New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida 2New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida 3KGI Announces Second Annual Executive Education Conference for Women in Life Sciences 2
(Date:11/20/2009)...s of plasma lipoprotein concentrations determined ...researchers led by Daniel Chasman at Brigham and W...on, MA, the Framingham Heart Study in Framingham, ...and Oxford, England performed genetic association ...n of European ancestry from the Women,s Genome Hea...
(Date:11/20/2009)...ibute their abstracts to the World Congress on Ost...bal meeting devoted to all aspects of osteoporosis... Congress will be held in Florence, Italy from May...submitted online at http://www.iofwco-ecceo10.org.... , IOF and ESCEO are pleased to announce that s...
(Date:11/20/2009)...of biological molecules like RNA and DNA is how th...simple precursors. Now, in a study appearing in th...cted one of the earliest evolutionary steps yet: g...its using nothing but warm water. , Many resear...ical molecules present, before DNA and proteins; h...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 4Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited 12888 1Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited 12888 2Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited 12888 3Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited 12888 4Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited 12888 5McCaughey Urges Use of First NYS Hospital Infection Report 4681 1
...hologists have long known that memories of disturb...or the unexpected death of a loved one - are more ...ne recollections of everyday matters. , Probing d...the University of Wisconsin-Madison have found tha... fire up two memory-forming regions of the brain -...
...d at first with nothing more than boots, a screen ... fish that makes up 70 percent of the biomass in T..." marking the point in evolution that led to the d..., The inch-long spineless fish, called a lancelet,...lar to but much hardier than the version found in ...
...essor of Microbiology at the Public University of ...ading an international project to sequence the gen...eam is composed of scientists from nineteen univer...apan, Israel and the United States. , The project...e annual competition of the Joint Genome Institute...
Other Biology News:Anticipation plays a powerful role in human memory, brain study finds 2Anticipation plays a powerful role in human memory, brain study finds 3Tiny Tampa Bay fish key to evolution of immune system 2Tiny Tampa Bay fish key to evolution of immune system 3Sequencing of the oyster mushroom genome 2Sequencing of the oyster mushroom genome 3Sequencing of the oyster mushroom genome 4
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor EcoR I Sma I from Takara Mirus Bio
Cassette, EcoR I from Takara Mirus Bio
Newborn Calf Serum from Lifeblood Medical, Inc.
Biology Products: